This discussion focused on measures industry stakeholders have taken for safe COVID-19 vaccine deployment and the immediate steps these stakeholders will take in the first 48 hours after the Emergency Use Authorization was approved.
- Snehal V. Gandhi, M.D., Medical Director, Division of Hospital Medicine, Cooper University Hospital
- Claire Hannan, MPH, Executive Director, Association of Immunization Managers (AIM)
- Ed Kaleta, Group Vice President, U.S. Government Relations, Walgreens
- Jay McHarg, MBA, CEO, AeroSafe Global
- Kate Sullivan Hare, Vice President of Policy & Communications, Alliance for Health Policy (moderator)